Scarring alopecia developing after mogamulizumab-associated rash

Eur J Dermatol. 2021 Dec 1;31(6):841-843. doi: 10.1684/ejd.2021.4179.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Alopecia / chemically induced*
  • Alopecia / pathology*
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antineoplastic Agents / adverse effects*
  • Cicatrix / chemically induced*
  • Cicatrix / pathology*
  • Drug Eruptions / etiology*
  • Exanthema / chemically induced
  • Exanthema / pathology
  • Female
  • Humans
  • Male
  • Sezary Syndrome / drug therapy

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • mogamulizumab